Skip to main content
Market intelligence
AMLXHealthcare

Amylyx Pharmaceuticals Inc insider activity

In the last 90 days, 1 corporate insider purchased $51,338 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$51,338
Corporate buyers
1
Latest transaction
May 21, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 21, 2026Karen FirestoneDirectorOpen Market Purchase3,800$13.51$51,338